Overview


According to FutureWise analysis the market for neurostimulation devices in 2023 is US$ 6.33 billion, and is expected to reach US$ 16.85 billion by 2031 at a CAGR of 13.00%.

Neurostimulation devices are medical devices that use electrical or magnetic stimulation to modulate the activity of the nervous system. These devices are designed to provide therapeutic effects by stimulating specific regions of the nervous system. They are used to treat various neurological and psychiatric disorders, such as chronic pain, Parkinson's disease, epilepsy, depression, and obsessive-compulsive disorder.

There are several types of neurostimulation devices, each of which uses a different method of stimulation. The most widely used one is transcutaneous electrical nerve stimulation (TENS), which delivers electrical stimulation to the nerves through the skin using electrodes. Another type of neurostimulation device is spinal cord stimulation (SCS), which involves implanting electrodes in the epidural space of the spinal cord. The electrodes are connected to a device that generates electrical impulses. Deep brain stimulation (DBS) is another type of neurostimulation device that involves implanting electrodes in specific regions of the brain. The electrodes are connected to a device that generates electrical impulses, which modulate the activity of the brain circuits involved in the targeted disorder. Other types of neurostimulation devices include vagus nerve stimulation (VNS), which involves implanting electrodes on the vagus nerve in the neck, and repetitive transcranial magnetic stimulation (rTMS), which is used to stimulate specific regions of the brain with the help of magnetic fields.

FutureWise Market Research has published a report that provides an insightful analysis of Neurostimulation Devices Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Neurostimulation Devices Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Medtronic 
  • St. Jude Medical 
  • Boston Scientific Corporation  
  • Cyberonics
  • Nevro Corporation
  • Neuronetics, Inc.
  • Uroplasty
  • Codman & Shurtleff’s
  • Intrapace
  • NeuroPace, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Neurostimulation Devices Market:

In January 2022, The US Food and Drug Administration granted Nevro Corp approval to expand the labeling of its Senza Spinal Cord Stimulation System for treating non-surgical refractory back pain.

Numerous significant factors are driving the market for neurostimulation devices, a rapidly expanding subsegment of the medical technology sector. One of the key drivers of market growth is the increasing prevalence of neurological disorders globally. According to the World Health Organization (WHO), neurological conditions affect approximately one billion people worldwide, with around 6.8 million deaths annually. As the incidence of these disorders continues to rise, the demand for neurostimulation devices is also increasing. The rising popularity of less invasive procedures is another element driving market expansion. Neurostimulation devices are often used in minimally invasive procedures, which have several benefits over traditional open surgeries, including shorter hospital stays, faster recovery times, and lower risk of complications. Furthermore, the rising awareness of the advantages of neurostimulation devices among patients and healthcare professionals is also contributing to the market's growth. As more patients seek alternative treatment options to manage their neurological conditions, the demand for these devices is likely to increase.

However, the high cost of these devices and the lack of reimbursement policies in many countries may hinder market growth. Additionally, the complexity of the devices and the need for specialized training to implant and use them may limit their adoption.

By Product Type

  • DBS (Deep-Brain Stimulation)
  • VNS (Vagus Nerve Stimulation)
  • RNS (Responsive Neuro Stimulation)
  • TMS (Transcranial Magnetic Stimulation)
  • SCS (Spinal Cord Stimulation)
  • PNS (Peripheral Nerve Stimulation)

By Application

  • Pain Management
  • Parkinson’s Disease
  • Urinary and Fecal Incontinence
  • Epilepsy
  • Hearing Loss
  • Gastroparesis
  • Depression
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. Market share for neurostimulation devices is anticipated to be dominated by North America. The growing elderly population, rising instances of neurological illnesses and spinal cord injuries among the elderly population, and the subsequent rise in demand for neurostimulation devices are the main drivers of the tremendous market growth. According to the "Spinal Cord Injury Facts and Stats" study, which was released in July 2022, every year, over 17,700 Americans suffer a spinal cord injury, with about 78% of them being men and an average age of 43. The increasing rate of spinal cord injuries in both adults and older people will thus fuel demand for neurostimulation devices and propel the industry. Launches and product approvals are a couple of the variables influencing the market's expansion. Thus, it is anticipated that growing company investment in the region, as well as rising incidences of neurological illnesses and spinal cord injuries, would boost market growth over the next years.

  • Tier 1 players- established companies in the market with major market share Tier 2 players New Entrants Emerging players which are growing rapidly
  • Tier 2 players
  • New Entrants
  • Emerging players which are growing rapidly
  • Growth prospects SWOT analysis Key trends Key data points affecting market growth
  • SWOT analysis
  • Key trends
  • Key data points affecting market growth
  • To provide with an exhaustive analysis on the Neurostimulation Devices Market By Product Type, By Application and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement 
  • The customization services offered are free of charge with purchase of any license of the report. 
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Neurostimulation Devices Market Variables, Trends and Scope
    •        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Neurostimulation Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Neurostimulation Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Neurostimulation Devices Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •       1. DBS (Deep-Brain Stimulation)
            2. VNS (Vagus Nerve Stimulation)
            3. RNS (Responsive Neuro Stimulation)
            4. TMS (Transcranial Magnetic Stimulation)
            5. SCS (Spinal Cord Stimulation)
            6. PNS (Peripheral Nerve Stimulation)

  • 8.   Neurostimulation Devices Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pain Management
        2. Epilepsy
        3. Essential Tremor
        4. Urinary and Fecal Incontinence
        5. Depression
        6. Dystonia
        7. Gastroparesis
        8. Parkinson's Disease
        9. Others

  • 9.   North America Neurostimulation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Neurostimulation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Neurostimulation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Neurostimulation Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Medtronic
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. St. Jude Medical
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Boston Scientific Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Cyberonics
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Nevro Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Neuronetics, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Uroplasty
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Codman and Shurtleff’s
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Intrapace
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. NeuroPace, Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients